Colorectal cancer prevention in inflammatory bowel disease and the role of 5-aminosalicylic acid: a clinical review and update.

Rubin DT, Cruz-Correa MR, Gasche C, Jass JR, Lichtenstein GR, Montgomery EA, Riddell RH, Rutter MD, Ullman TA, Velayos FS, Itzkowitz S. Colorectal cancer prevention in inflammatory bowel disease and the role of 5-aminosalicylic acid: a clinical review and update. Inflamm Bowel Dis. 2008 Feb; 14(2):265-74.

View in: PubMed

subject areas

Adenomatous Polyposis Coli
Anti-Inflammatory Agents, Non-Steroidal
Colorectal Neoplasms
Humans
Incidence
Inflammatory Bowel Diseases
Mesalamine
Precancerous Conditions
Prevalence
Terminology as Topic

authors with profiles

Marcia Cruz-Correa

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support